ArticleHealthcare (Basel, Switzerland)2025
Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.
Najla Bawazeer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.